Steven A Anderson
Overview
Explore the profile of Steven A Anderson including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
69
Citations
1295
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Deady M, Duncan R, Sonesen M, Estiandan R, Stimpert K, Cho S, et al.
J Med Internet Res
. 2024 Nov;
26:e54597.
PMID: 39586081
Background: Adverse events (AEs) associated with vaccination have traditionally been evaluated by epidemiological studies. More recently, they have gained attention due to the emergency use authorization of several COVID-19 vaccines....
2.
Jain S, Anderson S, Steele J, Wilson H, Muniz J, Soslow J, et al.
EClinicalMedicine
. 2024 Sep;
76:102809.
PMID: 39290640
Background: We aimed to study the clinical characteristics, myocardial injury, and longitudinal outcomes of COVID-19 vaccine-associated myocarditis (C-VAM). Methods: In this longitudinal retrospective observational cohort multicenter study across 38 hospitals...
3.
Pingray V, Belizan M, Matthews S, Zaraa S, Berrueta M, Noguchi L, et al.
Gates Open Res
. 2024 Jul;
5:99.
PMID: 39049963
Given that pregnant women are now included among those for receipt coronavirus disease 2019 (COVID-19) vaccines, it is important to ensure that information systems can be used (or available) for...
4.
Deady M, Duncan R, Jones L, Sang A, Goodness B, Pandey A, et al.
Front Public Health
. 2024 Jul;
12:1379973.
PMID: 39040857
Introduction: This study is part of the U.S. Food and Drug Administration (FDA)'s Biologics Effectiveness and Safety (BEST) initiative, which aims to improve the FDA's postmarket surveillance capabilities by using...
5.
Lu Y, Matuska K, Ma Y, Laniyan L, Chillarige Y, Anderson S, et al.
JAMA Netw Open
. 2024 Jul;
7(7):e2423926.
PMID: 39037818
No abstract available.
6.
Holdefer A, Pizarro J, Saunders-Hastings P, Beers J, Sang A, Hettinger A, et al.
JMIR Public Health Surveill
. 2024 Jul;
10:e49811.
PMID: 39008361
Background: Adverse events associated with vaccination have been evaluated by epidemiological studies and more recently have gained additional attention with the emergency use authorization of several COVID-19 vaccines. As part...
7.
Whitaker B, Huang Y, Gubernot D, Eder A, Herbenick D, Fu T, et al.
Transfusion
. 2024 Jun;
64(8):1459-1468.
PMID: 38864291
Background: In May 2023, the Food and Drug Administration (FDA) released final guidance for blood donor eligibility that recommended the elimination of 3-month deferral for men who have sex with...
8.
Shi X, Gruber J, Ondari M, Lloyd P, Freyria Duenas P, Clarke T, et al.
Vaccine
. 2024 May;
42(15):3486-3492.
PMID: 38704258
Background: While safety of influenza vaccines is well-established, some studies have suggested potential associations between influenza vaccines and certain adverse events (AEs). This study examined the safety of the 2022-2023...
9.
Ogilvie R, Layton J, Lloyd P, Jiao Y, Djibo D, Wong H, et al.
BMC Pediatr
. 2024 Apr;
24(1):276.
PMID: 38671379
Background: COVID-19 vaccines are authorized for use in children in the United States; real-world assessment of vaccine effectiveness in children is needed. This study's objective was to estimate the effectiveness...
10.
Hu M, Shoaibi A, Feng Y, Lloyd P, Wong H, Smith E, et al.
JAMA Netw Open
. 2024 Apr;
7(4):e248192.
PMID: 38656578
Importance: Active monitoring of health outcomes after COVID-19 vaccination provides early detection of rare outcomes that may not be identified in prelicensure trials. Objective: To conduct near-real-time monitoring of health...